C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2009
12/02/2009	EP2126127A2 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
12/02/2009	EP2126087A1 Methods of generating libraries and uses thereof
12/02/2009	EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
12/02/2009	EP2126049A1 Antibodies against human cytomegalovirus (hcmv)
12/02/2009	EP2125899A1 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
12/02/2009	EP2125898A2 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
12/02/2009	EP2125897A2 Monoclonal antibodies for treatment of cancer
12/02/2009	EP2125896A2 Anti-robo4 antibodies and uses therefor
12/02/2009	EP2125895A2 Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
12/02/2009	EP2125894A2 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
12/02/2009	EP2125893A2 Optimized cd40 antibodies and methods of using the same
12/02/2009	EP2125892A2 Nucleic acids encoding humanized immunoglobulin that binds a4b7 integrin
12/02/2009	EP2125891A2 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
12/02/2009	EP2125890A2 Antibodies to phosphorylated-irak4
12/02/2009	EP2125888A1 Method of providing human tumor-specific antibodies
12/02/2009	EP2125887A2 Compositions and methods for diagnosing and treating cancer
12/02/2009	EP2125886A2 Antibodies against h5n1 strains of influenza a virus
12/02/2009	EP2125880A1 Soluble il-17ra/rc fusion proteins and related methods
12/02/2009	EP2125015A1 Method for the treatment of amyloidoses
12/02/2009	EP2125013A1 Dll4 signaling inhibitors and uses thereof
12/02/2009	EP1732951B1 Monoclonal antibodies with specificity for fetal erythroid cells
12/02/2009	EP1664100B1 Lawsonia intracellularis subunit vaccine
12/02/2009	EP1248804B2 Recombinant antibodies to human interleukin-1 beta
12/02/2009	CN101595228A Multiple gene expression including SORF constructs and methods with polyproteins, pro-proteins, and proteolysis
12/02/2009	CN101595213A Cancerous disease modifying antibodies
12/02/2009	CN101595132A Use of thermostable biotin-binding protein and solid support having the protein bound thereto
12/02/2009	CN101595131A Methods of reducing phosphate absorption
12/02/2009	CN101595130A Compositions and methods for the diagnosis and treatment of tumor
12/02/2009	CN101594883A Diagnosis and treatment of cancer using anti-EREG antibody
12/02/2009	CN101594882A Interferon alpha-induced pharmacodynamic markers
12/02/2009	CN101591665A Slpa as a tool for recombinant protein and enzyme technology
12/02/2009	CN101591396A Anti-erbB2 human antibody MIL-5 and application thereof
12/02/2009	CN101591395A Human single chain antibody and application of antitumor vascular endothelium marker molecule 8-cell outer region
12/02/2009	CN101591394A Preparation of pairing monoclonal antibody aiming to dairy cow Y sperm specificity and application thereof
12/02/2009	CN101591393A Hydrophobia-tetanus double titer human immunoglobulin, method for preparing same and application thereof in pharmacy
12/02/2009	CN101591392A Enterovirus 71 type intravenous human immunoglobulin and preparation method thereof
12/02/2009	CN101591391A Enterovirus 71 type human immunoglobulin and preparation method thereof
12/02/2009	CN101591390A H5N1 derived avian influenza virus NP resistant monoclonal antibody and application thereof
12/02/2009	CN101591389A Varicella-zoster human immunoglobulin, method for preparing same and application thereof in pharmacy
12/02/2009	CN101591379A Constructed anti-HIV vaccine based on amino acid mutation of EIAV attenuated live vaccine
12/02/2009	CN100564531C Method for preparing swine N-acetglutamic acid synthetase polyclonal antibody and application thereof
12/02/2009	CN100564524C Factor involved in metastasis and uses thereof
12/02/2009	CN100564395C Human resource monoclonal antibody for anti-human P-selectin- epidermal growth factor functional region and hybridoma cell strain thereof
12/02/2009	CN100564394C Pefloxacin couple and its preparing method and use
12/02/2009	CN100563709C Novel targeted tissue factor antibody as anticoagulants
12/02/2009	CN100563707C Activation and inhibition of the immune system
12/01/2009	US7626013 HIV-1 DNA fragments that hybridize to genomic HIV-1DNA
12/01/2009	US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
12/01/2009	US7626011 Antibodies against tumor surface antigens
12/01/2009	US7626004 Using hydrophobic charge induction chromatography to isolate preferential immunoglobulins in mixture
12/01/2009	US7626002 Cytokine zalpha11 ligand antibodies
12/01/2009	US7625998 Human growth hormone domains
12/01/2009	US7625868 Methods and compositions for inhibiting angiogenesis
12/01/2009	US7625860 Administering a combination of a cytotoxic agent and a fibroblastic growth factor antagonist, wherein the FGF antagonist enhances the efficacy of the cytotoxic agent
12/01/2009	US7625859 HER-2 binding antagonists
12/01/2009	US7625756 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
12/01/2009	US7625751 WNV core protein/capsid interacting protein and uses of the same
12/01/2009	US7625743 Prokaryotic transgenic organism comprising a recombinant prokaryotic expression vector; bind toxins from Bacillus thuringiensis and thus to pesticides and pest resistance
12/01/2009	US7625725 Provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases; specifically described is nucleotide and amino acid sequence information for Pyrococcus furiousus PEF (P45), which was used to produce a recombinant PEF
12/01/2009	US7625710 Methods for determining 2F1-binding compounds
12/01/2009	US7625709 Reducing NgR-p75 mediated inhibition of axon regeneration
12/01/2009	US7625566 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides
12/01/2009	US7625563 Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
12/01/2009	US7625561 Diabody which specifically binds Streptococcus surface antigen I/II and methods of use thereof
12/01/2009	US7625560 Humanized antibodies that recognize beta amyloid peptide
12/01/2009	US7625559 Antibodies against Clostridium difficile toxins and uses thereof
12/01/2009	US7625558 Anticancer agents; administering nucleic acid which dimerizes with protein
12/01/2009	US7625549 Determining the risk of human anti-human antibodies in transgenic mice
12/01/2009	CA2316894C Polysaccharide conjugate capable of binding cellulose
12/01/2009	CA2303229C Pentopyranosylnucleoside, its preparation and use
12/01/2009	CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/01/2009	CA2107513C Fusion protein for prodrug activation
11/2009
11/26/2009	WO2009143526A1 Methods of treatment utilizing binding proteins of the interleukin-21 receptor
11/26/2009	WO2009143523A1 Interleukin-21 receptor binding proteins
11/26/2009	WO2009143472A2 Method of generating single vl domain antibodies in transgenic animals
11/26/2009	WO2009143083A2 Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm
11/26/2009	WO2009143081A2 Methods, devices kits and compositions for detecting roundworm
11/26/2009	WO2009143080A2 Methods, devices, kits and compositions for detecting roundworm
11/26/2009	WO2009143079A2 Methods, devices, kits and compositions for detecting roundworm
11/26/2009	WO2009143067A2 Methods, devices, kits and compositions for detecting whipworm
11/26/2009	WO2009142221A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
11/26/2009	WO2009142186A1 Cytotoxic composition
11/26/2009	WO2009141458A1 Antibody specific for propionylated/butyrylated lysine, method for obtaining same and uses thereof
11/26/2009	WO2009140755A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009	WO2009093246A3 Clusterin derived peptide
11/26/2009	WO2009090493A3 Tlr4 decoy receptor protein
11/26/2009	US20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/26/2009	US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009	US20090292111 ROR-alpha Promoting the Induction of Bmall
11/26/2009	US20090292109 Method of Isolating Biomacromolecules Using Polyalkylene Glycol and Transition Metals
11/26/2009	US20090291889 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
11/26/2009	US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009	US20090291493 Human immunodeficiency virus-neutralizing antibodies with improved breadth and potency
11/26/2009	US20090291472 Influenza nucleic acids, polypeptides, and uses thereof
11/26/2009	US20090291471 Novel Beta-Galactoside Alpha 2,6-Sialyltransferase, Gene Coding For The Transferase And Process For Producing The Same
11/26/2009	US20090291462 Detection or Quantification of Aggrecan and its Fragments
11/26/2009	US20090291460 Assay for transmissible spongiform encephalopathies
11/26/2009	US20090291459 Hybridoma capable of producing anti-dectin-1 monoclonal antibody
11/26/2009	US20090291455 Cynomolgus gp80 Receptor and Uses

1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 1494